Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes

Bibliographic Details
Main Authors: Peter Korsten, Maximilian F. Konig, Björn Tampe, Mehdi Mirsaeidi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.644075/full
id doaj-4d46cd2249e143cfae5b5db6c1bcaddb
record_format Article
spelling doaj-4d46cd2249e143cfae5b5db6c1bcaddb2021-01-20T06:49:50ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-01-01710.3389/fmed.2020.644075644075Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and OutcomesPeter Korsten0Maximilian F. Konig1Björn Tampe2Mehdi Mirsaeidi3Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, GermanyDivision of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, GermanyDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Miami Miller School of Medicine, Miami, FL, United Stateshttps://www.frontiersin.org/articles/10.3389/fmed.2020.644075/fullinterstitial lung diseaseautoimmune diseasesrheumatoid arthritissystemic sclerosis (scleroderma)myositis
collection DOAJ
language English
format Article
sources DOAJ
author Peter Korsten
Maximilian F. Konig
Björn Tampe
Mehdi Mirsaeidi
spellingShingle Peter Korsten
Maximilian F. Konig
Björn Tampe
Mehdi Mirsaeidi
Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
Frontiers in Medicine
interstitial lung disease
autoimmune diseases
rheumatoid arthritis
systemic sclerosis (scleroderma)
myositis
author_facet Peter Korsten
Maximilian F. Konig
Björn Tampe
Mehdi Mirsaeidi
author_sort Peter Korsten
title Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
title_short Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
title_full Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
title_fullStr Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
title_full_unstemmed Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
title_sort editorial: interstitial lung disease in the context of systemic disease: pathophysiology, treatment and outcomes
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2021-01-01
topic interstitial lung disease
autoimmune diseases
rheumatoid arthritis
systemic sclerosis (scleroderma)
myositis
url https://www.frontiersin.org/articles/10.3389/fmed.2020.644075/full
work_keys_str_mv AT peterkorsten editorialinterstitiallungdiseaseinthecontextofsystemicdiseasepathophysiologytreatmentandoutcomes
AT maximilianfkonig editorialinterstitiallungdiseaseinthecontextofsystemicdiseasepathophysiologytreatmentandoutcomes
AT bjorntampe editorialinterstitiallungdiseaseinthecontextofsystemicdiseasepathophysiologytreatmentandoutcomes
AT mehdimirsaeidi editorialinterstitiallungdiseaseinthecontextofsystemicdiseasepathophysiologytreatmentandoutcomes
_version_ 1724331255477043200